Document is current
Any future updates will be listed below
-
Authors
Heyne, Henrike O. https://orcid.org/0000-0001-9893-3850
Pajuste, Fanny-Dhelia https://orcid.org/0000-0002-6014-0537
Wanner, Julian https://orcid.org/0000-0002-1487-7909
Daniel Onwuchekwa, Jennifer I. https://orcid.org/0000-0002-7721-3202
Mägi, Reedik https://orcid.org/0000-0002-2964-6011
Palotie, Aarno https://orcid.org/0000-0002-2527-5874
,
,
Kälviainen, Reetta
Daly, Mark J. https://orcid.org/0000-0002-0949-8752
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (516649954)
Academy of Finland (312074, 312075)
- License Information
-
More Information
Article History
Received: 14 September 2023
Accepted: 4 July 2024
First Online: 25 July 2024
Competing interests
: M.J.D. is a founder of Maze Therapeutics. The remaining authors declare no competing interests.
